TY - JOUR
T1 - Biochemical mechanisms of generation of bradykinin by endotoxin
AU - Miller, Russell L.
AU - Reichgott, Michael J.
AU - Melmon, Kenneth L.
N1 - Funding Information:
This project was supported by research grant no. HL-09964 and training grant no. GM-01791 from the National Institutes of Health. Please address requests for reprints to Dr. Kenneth L. Melmon, Division of Clinical Pharmacology, Moffitt Hospital, Room 1089, University of California San Francisco Medical Center, San Francisco, California 94122. 1 M. J. Reichgott, R. P. Forsyth, D. K. Greineder, and
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1973/7
Y1 - 1973/7
N2 - The vasodilatory properties of bradykinin are compatible with a pathogenetic role in man and subhuman primates during endotoxemia. The peptide is generated during endotoxemia when peripheral vascular resistance is decreased. A number of mechanisms of kinin generation can be recruited by endotoxin. In plasma containing complement and 19S antibody to endotoxin, the polysaccharide moiety of endotoxin activates plasma kallikreins. Similar quantities of bradykinin are generated in all species tested. Therefore, species-related variation in production of the peptide in vivo depends on the interaction of endotoxin with other tissues. Granulocytes of primates (as opposed to those of rabbits) contain a cytoplasmic kallikrein or kallikrein activator. Granulocytes release their cytoplasmic enzymes (and presumably kallikreins) when phagocytizing endotoxin. In-vitro phagocytosis requires complement and lipid-rich endotoxin. Polysaccharide fractions of endotoxin do not produce effects on granulocytes, their kinin generation, or the cardiovascular system. We suggest that differences in endotoxin effect among species are largely related to effects of the lipid moiety of endotoxin and the chemical machinery of the cells this moiety penetrates.
AB - The vasodilatory properties of bradykinin are compatible with a pathogenetic role in man and subhuman primates during endotoxemia. The peptide is generated during endotoxemia when peripheral vascular resistance is decreased. A number of mechanisms of kinin generation can be recruited by endotoxin. In plasma containing complement and 19S antibody to endotoxin, the polysaccharide moiety of endotoxin activates plasma kallikreins. Similar quantities of bradykinin are generated in all species tested. Therefore, species-related variation in production of the peptide in vivo depends on the interaction of endotoxin with other tissues. Granulocytes of primates (as opposed to those of rabbits) contain a cytoplasmic kallikrein or kallikrein activator. Granulocytes release their cytoplasmic enzymes (and presumably kallikreins) when phagocytizing endotoxin. In-vitro phagocytosis requires complement and lipid-rich endotoxin. Polysaccharide fractions of endotoxin do not produce effects on granulocytes, their kinin generation, or the cardiovascular system. We suggest that differences in endotoxin effect among species are largely related to effects of the lipid moiety of endotoxin and the chemical machinery of the cells this moiety penetrates.
UR - http://www.scopus.com/inward/record.url?scp=0015642484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015642484&partnerID=8YFLogxK
U2 - 10.1093/infdis/128.Supplement_1.S144
DO - 10.1093/infdis/128.Supplement_1.S144
M3 - Article
C2 - 4719682
AN - SCOPUS:0015642484
SN - 0022-1899
VL - 128
SP - S144-S156
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
ER -